Cisplatin-vinorelbine combination chemotherapy in locally advanced non-small cell lung cancer

Tumori

Volumn 82, Issue 1, 1996, Pages 57-60

  Frontini, Luciano ^a   Candido, Paola ^b   Cattaneo, Maria Teresa ^b   Zonato, Sabrina ^a   Piatto, Ernesto ^c   Scapaticci, Roberto ^d   Isa, Luciano ^e   Raina, Alberto ^f   Lanzetti, Vittorio ^g   Pavia, Gianfranco ^h   Legnani, Walter ⁱ   Filipazzi, Virginio ^j   Rho, Benedetto ^j   Piazza, Elena ^b  

^a SAN PAOLO HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Ospedale Caduti Bollatesi   (Italy)

^d Manerbio Hospital   (Italy)

^e Gorgonzola Hospital   (Italy)

^f Sesto San Giovanni Hospital   (Italy)

^g Magenta Hospital   (Italy)

^h RHO HOSPITAL   (Italy)

ⁱ Abbiategrasso Hospital   (Italy)

^j Garbagnate Hospital   (Italy)

more..

Author keywords

cisplatin; IIIa IIIb; NSCLC; vinorelbine

Indexed keywords

CISPLATIN; GRANULOCYTE COLONY STIMULATING FACTOR; NAVELBINE;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CLINICAL TRIAL; CONSTIPATION; FEMALE; HUMAN; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PHASE 2 CLINICAL TRIAL; PHLEBITIS; THROMBOCYTOPENIA; VOMITING;

EID: 15844377601     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169608200112     Document Type: Article

References (14)

1. Balbiani L., Coppola F., Blajman C., Giachella F., Chacon O., Capò R., Decristofaro A., Feino O., Bass L., Lewi C., Burrè D., Van Koten I.: Navelbine (NVB) vs NVB plus cisplatin (P) in non-small cell lung cancer (NSCLC) (abstr 1185). Proc. Am. Soc. Clin. Oncol., 12: 352, 1993.
2. Cross S., Wright M., Morimoto C., Lataste H., Couzinier J.P., Krikorian A.: Experimental antitumor activity of navelbinc (5'-nor-anhydrovinblastine, vinorelbine). Sem. Oncol., 16 (suppl. 4): 15-20, 1989.
3. Dalphin J.C., Jacoulet P., Depierre A., Garnier G.: Study of combined navelbine-cisplatin-VP16 in the treatment of non-small cell lung cancer. In: Navelbine, Update and New Trends, Solal-Celigny P. (Ed.), pp 171-177, John Libbey Eurotext LTD, Paris, 1991.
4. Depierre A., Chastang C., Quoix E., Lebeau B., Blanchon F., Paillot N., Lemarie E., Milleron B., Moro D., Clavier J., Herman D., Tuchais E., Jacoulet P., Brechot J.M., Cordier J.F., Solal-Celigny P., Badri A., Besenval M.: Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer; a randomized trial. Ann. Oncol., 5: 37-42, 1994.
5. Depierre R., Le Marie E., Dabuis G., Garnier G., Jacoulet P., Delphin J.C.: A phase II study of navelbine (vinorelbine) in the treatment of non-small cell lung cancer. Am. Clin. Oncol., 14: 115-119, 1991.
6. Eagan R.T., Ruud C., Lee R.E., Pairolero P.C., Grail M.H.: Pilot study of induction therapy with cyclophosphamide, doxorubicin and cisplatin and chest irradiation prior to thoracotomy in initially inoperable stage III MO non-small cell lung cancer. Cancer Treat. Rep., 71: 895-900, 1987.
7. Gralla R.J.: Preoperative and adjuvant chemotherapy in non-small cell lung cancer. Semin. Oncol., 15 (suppl): 8-12, 1988.
8. Gralla R.I., Kris M.G., Potanovich L.M., Martini M., Burke M.T.: Enhancing the safety and efficacy of the MVP regimen (mitomycin+vinblastine+cisplatin) in 100 patients with inoperable non-small cell lung cancer (abstract). Proc. Am. Soc. Clin. Oncol., 8: 227, 1989.
9. Kaplan E.L., Meier P.: Non-parametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-81, 1958.
10. Samet J.M.: The epidemiology of lung cancer. Chest, 103: 20-29, 1993.
11. Sheperd F.A.: Etoposide/ifosfamide/cisplatinum in the treatment of advanced non-small cell lung cancer. Semin. Oncol., 19 (suppl) 1: 54-58, 1992.
12. Sheperd F.A.: Future direction in the treatment of non-small cell lung cancer. Semin. Oncol., 21 (suppl. 4): 48-62, 1994.
13. Souhami R.L.: Defining the role of chemotherapy in non-small-cell lung cancer. Ann. Oncol., 6: 317-318, 1995.
14. WHO Handbook for Reporting Results of Cancer Treatment. WHO offset publication, no. 48, WHO, Geneva, 1979.